Antibody-suppressor CXCR5+ CD8+ T cellular therapy ameliorates antibody-mediated rejection following kidney transplant in CCR5 KO mice.
Zimmerer JM, Han JL, Peterson CM, Zeng Q, Ringwald BA, Cassol C, Chaudhari S, Hart M, Hemminger J, Satoskar A, Abdel-Rasoul M, Wang JJ, Warren RT, Zhang ZJ, Breuer CK, Bumgardner GL.
Zimmerer JM, et al. Among authors: zeng q.
Am J Transplant. 2022 Jun;22(6):1550-1563. doi: 10.1111/ajt.16988. Epub 2022 Feb 15.
Am J Transplant. 2022.
PMID: 35114045
Free PMC article.